Merck

Gilead Sciences: How Big a Threat is Merck?
Barron's
Thu, 04/10/14 - 10:52 am
Gilead Sciences
Merck
hepatitis C
MK-5172
MK-8742
Sovaldi
Merck Data Show Potent Rival to Gilead’s Hepatitis C Pill
Bloomberg
Thu, 04/10/14 - 07:39 am
Merck
Gilead
hepatitis C
MK-5172
MK-8742
Sovaldi
Reckitt Benckiser Said to Have Edge for Merck OTC Unit
Bloomberg
Tue, 04/8/14 - 11:33 am
Reckitt Benckiser
Merck
OTC
M&A
This Biotech Market Could Quadruple -- 3 Stocks To Profit
Yahoo/Street Authority
Mon, 04/7/14 - 10:28 am
vaccines
Merck
Gardasil
Pfizer
Prevnar 13
Novavax
NanoViricides
Inovio
Merck, Ferring announce collaboration with WHO
The Fly on the Wall
Fri, 04/4/14 - 09:26 am
Merck
Ferring
WHO
3 Stocks Pushing The Drugs Industry Lower
TheStreet.com
Tue, 04/1/14 - 03:01 pm
Bristol-Myers Squibb
Merck
Pfizer
Makings of a Wide Moat in Diabetes Care
Morningstar
Fri, 03/28/14 - 11:16 am
diabetes
Takeda
Sanofi
GSK
Victoza
Merck
insulin
Novo Nordisk
Afrezza
U300
Tresiba
Eli Lilly
Overall Survival Will Be Critical for Endocyte's Vintafolide
Motley Fool
Fri, 03/28/14 - 10:18 am
Endocyte
vintafolide
Merck
ovarian cancer
Merck, GlaxoSmithKline halt copay help for Obamacare patients
Fierce Pharma
Thu, 03/27/14 - 11:24 am
anti-kickback statute
GSK
Merck
copays
Affordable Care Act
Who's going to win pharma's immunotherapy gold rush?
Fierce Biotech
Tue, 03/25/14 - 08:08 am
immunotherapy
Roche
Bristol-Myers Squibb
Merck
PDL-1
anti-PD-1 immunotherapy
melanoma
Sanofi Said to Join Bidders for Merck’s Consumer-Health Business
Bloomberg
Mon, 03/24/14 - 06:21 pm
Sanofi
Merck
M&A
consumer health
Endocyte, Merck Cancer Drug Scores Twice
investors.com
Sat, 03/22/14 - 11:36 am
Endocyte
Merck
Vynfinit
ovarian cancer
They're no Coca-Cola, but top biopharma brands Pfizer, Biogen and Merck still worth billions
Fierce Pharma Marketing
Fri, 03/21/14 - 10:44 am
Pfizer
Biogen Idec
Merck
Did Endocyte Just Become Buyout Bait?
Wall St 24/7
Fri, 03/21/14 - 10:39 am
Endocyte
M&A
Merck
vintafolide
EMA committee backs conditional approval of Merck & Co., Endocyte's Vynfinit for ovarian cancer
First Word Pharma
Fri, 03/21/14 - 08:50 am
Europe
Merck
Endocyte
Vynfinit
ovarian cancer
Merck HIV Drug Strategy Seen Shielding Patent: Corporate India
Bloomberg
Thu, 03/20/14 - 08:30 am
HIV
Merck
India
Cipla
Isentress
patents
Bristol-Myers inks a $350M deal to pair with Five Prime on immuno-oncology gold rush
Fierce Biotech
Mon, 03/17/14 - 10:53 am
MK-3475
Merck
Five Prime
cancer immunotherapy
Bristol-Myers Squibb
FDA Concerns Are the Least of These Drugs' Worries
Motley Fool
Mon, 03/17/14 - 09:53 am
FDA
PCSK9 inhibitors
Regeneron
Sanofi
Merck
alirocumab
Coffee Fuels Drive for Drugs for Parkinson’s to Dementia
Bloomberg
Mon, 03/17/14 - 08:34 am
caffeine
Parkinson's Disease
Merck
Kyowa Hakko Kirin
Nouriast
Gilead's hot-selling Sovaldi draws more patent attacks
Fierce Pharma
Fri, 03/14/14 - 11:15 am
Sovaldi
Idenix
Merck
Roche
hepatitis C
patents
Gilead Sciences

Pages